To investigate the prevalence of the ACTN3 R577X polymorphism in patients with end-stage renal disease undergoing hemodialysis (HD) and explore its potential involvement in renal fibrosis through experimental models. The gene discussed is ACTN3; the disease is chronic kidney disease.